Showing results (1381-1390 of 2,175) with videos related to
Sort By:
Pageof 218
Food & Function|May 24, 2018
Rooibos tea extracts inhibit osteoclast formation and activity through the attenuation of NF-κB activity in RAW264.7 murine macrophagesShaakirah Moosa, Abe E Kasonga, Vishwa Deepak, et al.Journal of Medical Virology|July 4, 2007
Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasiaJo-Ann S Passmore, Dianne J Marais, Candice Sampson, et al.Plos One|October 14, 2016
Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, AustraliaUlziijargal Gurjav, Alexander C Outhred, Peter Jelfs, et al.The Journal of Antimicrobial Chemotherapy|December 11, 2014
Added value of whole-genome sequencing for management of highly drug-resistant TBAlexander C Outhred, Peter Jelfs, Basel Suliman, et al.Polymers|September 3, 2020
The Impact of Reactive Ionic Liquids Addition on the Physicochemical and Sorption Properties of Poly(Vinyl Alcohol)-Based FilmsGuoqiang Li, Edyta Rynkowska, Kateryna Fatyeyeva, et al.Frontiers in Public Health|September 25, 2020
Extensive Homoplasy but No Evidence of Convergent Evolution of Repeat Numbers at MIRU Loci in Modern Mycobacterium tuberculosis LineagesAlexander C Outhred, Ulziijargal Gurjav, Peter Jelfs, et al.Pathology|October 22, 2019
Invasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostainingBenjamin Dessauvagie, Anitha Thomas, Carla Thomas, et al.Revue Neurologique|July 3, 2026
Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal studyR Demeret, D Vieles Marais, E Treiner, et al.Emerging Infectious Diseases|July 22, 2015
Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011Claudia C Dobler, Sarah Korver, Ochirbat Batbayar, et al.Cancer Research|October 5, 2006
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signalingNicolas Dumaz, Robert Hayward, Jan Martin, et al.Pageof 218